FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer. Apr 2009 - Clin. Immunol.; 131(1):1521-7035 [PMID:19201656] [Rozková D] [Tiserová H] [Fucíková J] [Last'ovicka J] [Podrazil M] [Ulcová H] [Budínský V] [Prausová J] [Linke Z] [Minárik I] [Sedivá A] [Spísek R] [Bartůnková J]
